Revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | £3.58B | £3.55B | £3.67B | £3.84B | £3.43B | £3.40B | £3.87B | £4.13B | £4.51B | £4.55B | £4.47B |
| Gross profit | £1.86B | £1.81B | £1.83B | £1.79B | £1.68B | £1.63B | £2.01B | £2.19B | £2.45B | £2.46B | £2.49B |
| Gross margin | 52.00% | 50.99% | 49.95% | 46.73% | 49.04% | 47.98% | 51.98% | 52.94% | 54.22% | 54.02% | 55.66% |
| Research & development | £8.0M | £6.0M | £8.0M | £10.0M | £12.0M | £11.0M | £13.0M | £14.0M | £14.0M | £23.0M | £33.0M |
| Operating expenses | £3.07B | £3.01B | £3.18B | £3.57B | £3.25B | £2.99B | £3.65B | £3.62B | £4.14B | £7.15B | £4.92B |
| Operating income | £507.0M | £541.0M | £498.0M | £271.0M | £183.0M | £411.0M | £275.0M | £553.0M | £451.0M | −£2.50B | −£404.0M |
| Operating margin | 14.17% | 15.23% | 13.55% | 7.06% | 5.34% | 12.10% | 7.11% | 13.39% | 9.99% | −54.86% | −9.04% |
| EBITDA | £1.10B | £1.11B | £1.10B | £1.01B | — | £536.0M | £398.0M | £619.0M | £541.0M | −£2.40B | −£329.0M |
| EBITDA margin | 30.84% | 31.39% | 29.86% | 26.30% | — | 15.78% | 10.29% | 14.99% | 11.99% | −52.77% | −7.36% |
| Net income | £336.0M | £435.0M | £380.0M | £244.0M | £178.0M | £330.0M | £266.0M | £590.0M | £408.0M | −£2.33B | £823.0M |
| Net profit margin | 9.39% | 12.25% | 10.34% | 6.35% | 5.19% | 9.71% | 6.88% | 14.29% | 9.04% | −51.30% | 18.42% |
| Basic EPSper basic share | £0.51 | £0.65 | £0.53 | £0.33 | £0.24 | £0.44 | £0.34 | £0.76 | £0.50 | -£2.87 | £1.01 |
| Diluted EPSper diluted share | £0.51 | £0.64 | £0.53 | £0.33 | £0.23 | £0.44 | £0.34 | £0.76 | £0.50 | -£2.87 | £1.01 |